Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune checkpoint inhibitors and endocrine side effects, a narrative review.

Postgraduate medicine·2019
Same author

Noradrenergic depletion causes sex specific alterations in the endocannabinoid system in the Murine prefrontal cortex.

Neurobiology of stress·2019
Same author

High resolution approaches for the identification of amyloid fragments in brain.

Journal of neuroscience methods·2018
Same author

Catecholamine dysregulation and neurodegenerative disease: From molecular mechanisms to circuit dysfunction.

Brain research·2018
Same author

Cortical adrenoceptor expression, function and adaptation under conditions of cannabinoid receptor deletion.

Experimental neurology·2017
Same author

Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety.

Brain structure & function·2016

Related Experiment Video

Updated: Jun 1, 2026

Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction
08:11

Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction

Published on: August 25, 2017

Intracisternal rSV40 administration provides effective pan-CNS transgene expression.

J-P Louboutin1, B A S Reyes, L Agrawal

  • 1Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA, USA. jplouboutin@hotmail.com

Gene Therapy
|May 27, 2011
PubMed
Summary

Gene therapy using antioxidant-carrying vectors delivered to the cisterna magna (CM) achieved widespread central nervous system (CNS) expression. This approach demonstrated significant neuroprotection against HIV-1 gp120-induced damage in a rat model.

More Related Videos

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Related Experiment Videos

Last Updated: Jun 1, 2026

Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction
08:11

Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction

Published on: August 25, 2017

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Area of Science:

  • Neuroscience
  • Gene Therapy
  • Molecular Biology

Background:

  • Generalized central nervous system (CNS) diseases often necessitate broad transgene expression for effective genetic treatment.
  • Oxidative stress and apoptosis, exemplified by HIV-1 envelope gp120, are key pathological mechanisms in various CNS disorders.
  • Developing methods for pan-CNS gene delivery is crucial for treating widespread neurological conditions.

Purpose of the Study:

  • To investigate the efficacy of pan-CNS neuroprotective gene delivery into the cisterna magna (CM).
  • To utilize recombinant simian virus 40 (rSV40) vectors carrying antioxidant enzymes (Cu/Zn superoxide dismutase or glutathione peroxidase) for gene delivery.
  • To model oxidant stress and apoptosis using HIV-1 envelope gp120 in a rat system.

Main Methods:

  • Recombinant SV40 vectors encoding antioxidant genes were injected into the rat CM after mannitol administration.
  • Transgene expression levels and distribution throughout the CNS were monitored.
  • Rats were subsequently challenged with HIV-1 gp120 in the caudate putamen to assess neuroprotection.

Main Results:

  • Sustained transgene expression was observed in neurons across the entire CNS.
  • Intracisternal administration of antioxidant-carrying rSV40 vectors resulted in significant neuroprotection.
  • The treatment effectively countered the neurotoxic effects of gp120.

Conclusions:

  • Intracisternal delivery of antioxidant-carrying rSV40 vectors enables widespread CNS transgene expression.
  • This gene delivery strategy shows promise for treating CNS diseases associated with oxidative stress, such as HIV-1-associated neurocognitive disorders.
  • The findings support the potential of this approach for managing widespread neurodegenerative conditions.